Peter Swaan Named Distinguished University Professor
May 18, 2022
Professor and chair of the Department of Pharmaceutical Sciences receives highest appointment for University of Maryland, Baltimore faculty.
May 18, 2022
Professor and chair of the Department of Pharmaceutical Sciences receives highest appointment for University of Maryland, Baltimore faculty.
April 7, 2022
UMSOP PhD candidate helped develop an innovative method for automated analysis of the higher order structure of proteins in biological models, allowing for complex in vivo drug design and modeling.
March 7, 2022
Two pharmaceutical sciences professors are collaborating to research the regulation of heme utilization in Pseudomonas aeruginosa.
January 12, 2022
Grollman-Glick Professor of Pharmaceutical Sciences recognized for work on use of computers in chemical and pharmaceutical research.
January 1, 2022
New center strives to help develop generics and patients who need them
December 9, 2021
Bruce Yu, PhD, is one of eight professors from the University of Maryland, Baltimore and the University of Maryland, College Park awarded $150,000 each over three years.
September 15, 2021
Multi-Disciplinary Team of Researchers – Including UMSOP’s Mass Spectrometry Experts – Identify Mechanism of Protection Conferred by Probiotic Supplement
September 10, 2021
Five-year grant supports research on nanoparticles’ design on inflammatory responses
November 23, 2020
Award from the Maryland Industrial Partnerships (MIPS) program supports work to formulate Clofazimine for treatment of recurrent C. difficile infections.
September 29, 2020
New center established by the School of Pharmacy, in collaboration with the University of Michigan, will increase access to safe and effective generic drugs through collaborative research, training, and exchange.
September 22, 2020
Meeting brings together 360 stakeholders from across academia, government, and industry to explore methods to develop better models that can identify and accurately predict drug risks and efficacy.
September 16, 2020
Information about the molecular shape of the viruses that cause COVID-19, SARS, and MERS reveals structural similarities that suggest possible drug treatments.